{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:04:38Z","timestamp":1754485478968},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,21]]},"DOI":"10.7759\/cureus.20569","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:08:03Z","timestamp":1640102883000},"source":"Crossref","is-referenced-by-count":10,"title":["Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Simple","family":"Bhadania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Bhalodiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashendra","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirja","family":"Kaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad Ullah","family":"Wasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya S","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenisha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i1.9397","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta D","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020, 91:157-60. 10.23750\/abm.v91i1.9397","journal-title":"Acta Biomed"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song G","year":"2020","unstructured":"Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020, 185:599-606. 10.1007\/s11046-020-00462-9","journal-title":"Mycopathologia"},{"key":"ref3","unstructured":"India reports 40,854 cases of black fungus so far. (2021). Accessed. October 10, 2021:  https:\/\/www.livemint.com\/news\/india-records-over-40k-cases-of-mucormycosis-11624875874985.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jof4020046","article-title":"Mucormycosis: battle with the deadly enemy over a five-year period in India","volume":"4","author":"Chander J","year":"2018","unstructured":"Chander J, Kaur M, Singla N, et al.. Mucormycosis: battle with the deadly enemy over a five-year period in India. J Fungi (Basel). 2018, 4:46. 10.3390\/jof4020046","journal-title":"J Fungi (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.09.004","article-title":"COVID19 associated mucormycosis: is GRP78 a possible link?","volume":"14","author":"Gumashta J","year":"2021","unstructured":"Gumashta J, Gumashta R. COVID19 associated mucormycosis: is GRP78 a possible link?. J Infect Public Health. 2021, 14:1351-7. 10.1016\/j.jiph.2021.09.004","journal-title":"J Infect Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim AS","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012, 54:S16-22. 10.1093\/cid\/cir865","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg B","year":"2005","unstructured":"Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005, 18:556-69. 10.1128\/CMR.18.3.556-569.2005","journal-title":"Clin Microbiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.105957","article-title":"Sino-orbital mucormycosis in a COVID-19 patient: a case report","volume":"82","author":"Maini A","year":"2021","unstructured":"Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V. Sino-orbital mucormycosis in a COVID-19 patient: a case report. Int J Surg Case Rep. 2021, 82:105957. 10.1016\/j.ijscr.2021.105957","journal-title":"Int J Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich A","year":"2021","unstructured":"Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021, 42:264.e5-8. 10.1016\/j.ajem.2020.09.032","journal-title":"Am J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070319","article-title":"Invasive and non-invasive fungal rhinosinusitis-a review and update of the evidence","volume":"55","author":"Deutsch PG","year":"2019","unstructured":"Deutsch PG, Whittaker J, Prasad S. Invasive and non-invasive fungal rhinosinusitis-a review and update of the evidence. Medicina (Kaunas). 2019, 55:319. 10.3390\/medicina55070319","journal-title":"Medicina (Kaunas)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080616","article-title":"Connecting the dots: interplay of pathogenic mechanisms between COVID-19 disease and mucormycosis","volume":"7","author":"Prakash H","year":"2021","unstructured":"Prakash H, Skiada A, Paul RA, Chakrabarti A, Rudramurthy SM. Connecting the dots: interplay of pathogenic mechanisms between COVID-19 disease and mucormycosis. J Fungi (Basel). 2021, 7:616. 10.3390\/jof7080616","journal-title":"J Fungi (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116419","article-title":"Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies","volume":"91","author":"Boelaert JR","year":"1993","unstructured":"Boelaert JR, de Locht M, Van Cutsem J, et al.. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993, 91:1979-86. 10.1172\/JCI116419","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13353","article-title":"Mucormycosis and COVID-19: an epidemic within a pandemic in India","volume":"64","author":"Selarka L","year":"2021","unstructured":"Selarka L, Sharma S, Saini D, et al.. Mucormycosis and COVID-19: an epidemic within a pandemic in India. Mycoses. 2021, 64:1253-60. 10.1111\/myc.13353","journal-title":"Mycoses"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00217-3","article-title":"Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials","volume":"7","author":"Raju R","year":"2021","unstructured":"Raju R, V P, Biatris PS, J SJ. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Futur J Pharm Sci. 2021, 7:67. 10.1186\/s43094-021-00217-3","journal-title":"Futur J Pharm Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.53","article-title":"Diabetes mellitus and its complications in India","volume":"12","author":"Unnikrishnan R","year":"2016","unstructured":"Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016, 12:357-70. 10.1038\/nrendo.2016.53","journal-title":"Nat Rev Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.72","article-title":"Ferritin levels and COVID-19","volume":"44","author":"Vargas-Vargas M","year":"2020","unstructured":"Vargas-Vargas M, Cort\u00e9s-Rojo C. Ferritin levels and COVID-19. Rev Panam Salud Publica. 2020, 44:e72. 10.26633\/RPSP.2020.72","journal-title":"Rev Panam Salud Publica"},{"key":"ref17","article-title":"Ferritin as a marker of severity in COVID-19 patients: a fatal correlation","volume":"22","author":"Dahan S","year":"2020","unstructured":"Dahan S, Segal G, Katz I, et al.. Ferritin as a marker of severity in COVID-19 patients: a fatal correlation. Israel Med Assoc J. 2020, 22:494-500.","journal-title":"Israel Med Assoc J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim AS","year":"2008","unstructured":"Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008, 21:620-5. 10.1097\/QCO.0b013e3283165fd1","journal-title":"Curr Opin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02976.x","article-title":"The role of iron and iron chelators in zygomycosis","volume":"15","author":"Symeonidis AS","year":"2009","unstructured":"Symeonidis AS. The role of iron and iron chelators in zygomycosis. Clin Microbiol Infect. 2009, 15:26-32. 10.1111\/j.1469-0691.2009.02976.x","journal-title":"Clin Microbiol Infect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis WM","year":"1982","unstructured":"Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes. 1982, 31:1109-14. 10.2337\/diacare.31.12.1109","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111228","article-title":"The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators","volume":"136","author":"Habib HM","year":"2021","unstructured":"Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 2021, 136:111228. 10.1016\/j.biopha.2021.111228","journal-title":"Biomed Pharmacother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myw014","article-title":"The environmental source of emerging Apophysomyces variabilis infection in India","volume":"54","author":"Prakash H","year":"2016","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, Paul RA, Gupta S, Negi V, Chakrabarti A. The environmental source of emerging Apophysomyces variabilis infection in India. Med Mycol. 2016, 54:567-75. 10.1093\/mmy\/myw014","journal-title":"Med Mycol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02972.x","article-title":"The ecology of the Zygomycetes and its impact on environmental exposure","volume":"15","author":"Richardson M","year":"2009","unstructured":"Richardson M. The ecology of the Zygomycetes and its impact on environmental exposure. Clin Microbiol Infect. 2009, 15:2-9. 10.1111\/j.1469-0691.2009.02972.x","journal-title":"Clin Microbiol Infect"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019, 5:26. 10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review","volume":"10","author":"Cavezzi A","year":"2020","unstructured":"Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020, 10:1271. 10.4081\/cp.2020.1271","journal-title":"Clin Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01546-2","article-title":"Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study","volume":"21","author":"Sonnweber T","year":"2020","unstructured":"Sonnweber T, Boehm A, Sahanic S, et al.. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study. Respir Res. 2020, 21:276. 10.1186\/s12931-020-01546-2","journal-title":"Respir Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1831383","article-title":"D-dimer level in COVID-19 infection: a systematic review","volume":"13","author":"Rostami M","year":"2020","unstructured":"Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020, 13:1265-75. 10.1080\/17474086.2020.1831383","journal-title":"Expert Rev Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.11.2669","article-title":"Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection","volume":"27","author":"Lecube A","year":"2004","unstructured":"Lecube A, Hern\u00e1ndez C, Genesc\u00e0 J, Esteban JI, Jard\u00ed R, Garc\u00eda L, Sim\u00f3 R. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care. 2004, 27:2669-75. 10.2337\/diacare.27.11.2669","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/genes11111296","article-title":"Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance","volume":"11","author":"Stanford FA","year":"2020","unstructured":"Stanford FA, Voigt K. Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance. Genes (Basel). 2020, 11:1296. 10.3390\/genes11111296","journal-title":"Genes (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78672-hyperferritinemia-and-the-extent-of-mucormycosis-in-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:54Z","timestamp":1707507294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78672-hyperferritinemia-and-the-extent-of-mucormycosis-in-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.20569","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}